US Stock MarketDetailed Quotes

GRCE Grace Therapeutics

Watchlist
  • 3.230
  • -0.050-1.52%
Close Nov 21 16:00 ET
  • 3.230
  • 0.0000.00%
Post 20:01 ET
32.75MMarket Cap-3549P/E (TTM)

About Grace Therapeutics Company

Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002, and is headquartered in Princeton, NJ.

Company Profile

SymbolGRCE
Company NameGrace Therapeutics
Listing DateJan 7, 2013
Founded2002
CEOMr. Prashant Kohli
MarketNASDAQ
Employees7
Fiscal Year Ends03-31
Address103 Carnegie Center,Suite 300
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-818-839-4378
Websitehttp://www.gracetx.com

Company Executives

  • Name
  • Position
  • Salary
  • Prashant Kohli
  • Chief Executive Officer and Director
  • 987.63K
  • Dr. R. Loch Macdonald, M.D.,PhD
  • Chief Medical Officer
  • --
  • Robert J. DelAversano
  • Vice President, Finance, Principal Financial Officer and Principal Accounting Officer
  • --
  • Carrie D'Andrea
  • Vice President, Clinical Operations
  • 383.00K
  • Amresh Kumar, PhD
  • Vice President, Program Management
  • 378.02K
  • Vimal Kavuru
  • Chairman of the Board
  • 127.43K
  • Dr. S. George Kottayil, PhD
  • Director
  • 44.90K
  • Edward Neugeboren
  • Independent Director
  • 53.00K
  • A. Brian Davis
  • Independent Director
  • 57.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data